Xiaoliu Liang

595 total citations
19 papers, 460 citations indexed

About

Xiaoliu Liang is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Xiaoliu Liang has authored 19 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Cancer Research. Recurrent topics in Xiaoliu Liang's work include Nanoplatforms for cancer theranostics (4 papers), Cancer Mechanisms and Therapy (2 papers) and Fibroblast Growth Factor Research (2 papers). Xiaoliu Liang is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Cancer Mechanisms and Therapy (2 papers) and Fibroblast Growth Factor Research (2 papers). Xiaoliu Liang collaborates with scholars based in China, Macao and United States. Xiaoliu Liang's co-authors include Min Su, Meizhen Liu, Bin Yang, Chao Guo, Ka Wu, Rong Li, Yujia Liang, Xinmou Wu, Rui Zhou and Gang Liu and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Chemical Engineering Journal.

In The Last Decade

Xiaoliu Liang

19 papers receiving 456 citations

Peers

Xiaoliu Liang

PHARM

EPIDE

Tiantian Xu China

Fatemeh Kheradmand Iran

Mohamed N. Amin Egypt

Xiawen Yang China

Arash Ghasemi Iran

Fuda Xie China

John E. Seng United States

Joseph A. Cichocki United States

Miao Hu China

Alice Limonciel Austria

Tiantian Xu China

Xiaoliu Liang

248 ×1.5

76 ×1.3

43 ×0.8

40 ×0.8

PHARM

100 ×2.2

EPIDE

Citations per year, relative to Xiaoliu Liang Xiaoliu Liang (= 1×) peers Tiantian Xu

Countries citing papers authored by Xiaoliu Liang

Since Specialization

Citations

This map shows the geographic impact of Xiaoliu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliu Liang more than expected).

Fields of papers citing papers by Xiaoliu Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliu Liang. The network helps show where Xiaoliu Liang may publish in the future.

Co-authorship network of co-authors of Xiaoliu Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliu Liang. A scholar is included among the top collaborators of Xiaoliu Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliu Liang. Xiaoliu Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Chen, Hu, Qihui Hu, Xiaoliu Liang, et al.. (2025). Carrier-free methylene blue nanomedicine for prolonged hepatic visualization in anatomical hepatectomy: A translational study from bench to bedside. Chemical Engineering Journal. 520. 166075–166075. 1 indexed citations

Liang, Xiaoliu, Xue Liu, Yang Zhang, et al.. (2024). Sono‐Triggered Biomimetically Nanoantibiotics Mediate Precise Sequential Therapy of MRSA‐Induced Lung Infection. Advanced Materials. 36(46). e2403612–e2403612. 17 indexed citations

Liu, Hui, et al.. (2024). Supercritical Fluids: An Innovative Strategy for Drug Development. Bioengineering. 11(8). 788–788. 11 indexed citations

Liang, Xiaoliu, Zhenjie Li, Chi Zhang, et al.. (2024). Cerenkov radiation shining a light for cancer theranostics. Nano Today. 55. 102174–102174. 13 indexed citations

Xue, Yi, Xiaoliu Liang, Pan He, et al.. (2023). Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy. Advanced Functional Materials. 34(11). 6 indexed citations

He, Pan, En Ren, Biao‐Qi Chen, et al.. (2022). A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. Theranostics. 12(4). 1769–1782. 44 indexed citations

Xiao, Hai, Ka Wu, Xiaoliu Liang, Rong Li, & Keng Po Lai. (2021). Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis. Frontiers in Immunology. 12. 715036–715036. 16 indexed citations

Liang, Yujia, et al.. (2020). Pharmacological targets and mechanisms of calycosin against meningitis. Aging. 12(19). 19468–19492. 21 indexed citations

Liang, Yujia, et al.. (2020). Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study. European Journal of Pharmacology. 881. 173227–173227. 21 indexed citations

10.

Liang, Xiaoliu, et al.. (2019). Effect of prenatal PFOS exposure on liver cell function in neonatal mice. Environmental Science and Pollution Research. 26(18). 18240–18246. 18 indexed citations

11.

Wu, Ka, et al.. (2019). To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis. Journal of Advanced Research. 20. 43–50. 48 indexed citations

12.

Guo, Chao, et al.. (2019). Potential biomarker of fibroblast growth factor 21 in valproic acid‐treated livers. BioFactors. 45(5). 740–749. 18 indexed citations

13.

Zhou, Rui, Meizhen Liu, Xiaoliu Liang, Min Su, & Rong Li. (2019). Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells. Environmental Toxicology and Pharmacology. 71. 103225–103225. 38 indexed citations

14.

Guo, Chao, Ka Wu, Xiaoliu Liang, Yujia Liang, & Rong Li. (2019). Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysis. Pharmacological Research. 148. 104455–104455. 34 indexed citations

15.

Liu, Meizhen, Rui Zhou, Xiaoliu Liang, et al.. (2019). Antineoplastic effects of sorafenib on primary liver cancer: a systematic review and meta-analysis.. PubMed. 12(7). 2389–2397. 2 indexed citations

16.

Liang, Xiaoliu, Ka Wu, Meizhen Liu, & Bin Yang. (2019). Adverse impact of carbon tetrachloride on metabolic function in mice. Journal of Cellular Biochemistry. 120(7). 11973–11980. 5 indexed citations

17.

Li, Rong, et al.. (2019). Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid. Journal of Cellular and Molecular Medicine. 23(9). 6017–6023. 30 indexed citations

18.

Su, Min, Chao Guo, Meizhen Liu, Xiaoliu Liang, & Bin Yang. (2018). Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacology. International Immunopharmacology. 66. 383–387. 76 indexed citations

19.

Su, Min, Xiaoliu Liang, Xiaoxiao Xu, Xinmou Wu, & Bin Yang. (2018). Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress. Environmental Toxicology and Pharmacology. 65. 60–65. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact